Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016200608> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2016200608 endingPage "2340" @default.
- W2016200608 startingPage "2334" @default.
- W2016200608 abstract "Two-thirds of patients with squamous cell carcinomas of the head and neck (SCCHN) at diagnosis have advanced disease with projected 5-year survival rates of 30%. In those patients with distant metastatic or previously treated recurrent disease, response rate to the standard regimen of cisplatin and 5-fluorouracil is approximately 30%. The authors investigated the use of paclitaxel and carboplatin in a limited Phase II study in recurrent or metastatic SCCHN to evaluate tumor response, time to progression, survival, and toxicities of this regimen.Patients with recurrent or metastatic SCCHN not amenable to further surgical or radiation therapy were treated with 200 mg/m(2) by 3-hour infusion of paclitaxel followed by carboplatin at an area under the concentration time curve of 6 mg/mL/minute via a 20-30-minute infusion every 3 weeks.Thirty-seven patients were enrolled. Ninety-five percent of patients had received prior surgery and postoperative radiotherapy. The overall response rate was 27% (95% confidence interval, 13-41%) with 1 complete and 9 PRs. Median survival of all patients was 4.9 months, and 1-year survival rate was 16%. There was a 43% response rate and 15.7-month median survival rate in patients with only distant metastatic disease and 38% response rate and a 4.5-month median survival in patients with locoregional and metastatic disease. The response rate for patients with only locoregional recurrence was 7% with a median survival of 4.8 months. Grade 3-4 myelotoxicity occurred in 24% of cycles administered. There were two treatment-related deaths due to neutropenic fever and one additional death on study may have been caused by treatment-induced thrombocytopenia.The combination of paclitaxel and carboplatin is significantly myelotoxic and ineffective in patients with previously treated locoregionally recurrent SCCHN, whereas it deserves further evaluation in those patients with distant metastatic disease alone. In those patients with locoregional disease, other more innovative treatments are needed." @default.
- W2016200608 created "2016-06-24" @default.
- W2016200608 creator A5000174010 @default.
- W2016200608 creator A5021230077 @default.
- W2016200608 creator A5031440445 @default.
- W2016200608 creator A5033516554 @default.
- W2016200608 creator A5034792001 @default.
- W2016200608 creator A5061478990 @default.
- W2016200608 creator A5066416973 @default.
- W2016200608 creator A5088048973 @default.
- W2016200608 creator A5089439580 @default.
- W2016200608 date "2001-01-01" @default.
- W2016200608 modified "2023-09-30" @default.
- W2016200608 title "Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma" @default.
- W2016200608 cites W1723772693 @default.
- W2016200608 cites W1845622004 @default.
- W2016200608 cites W1898337686 @default.
- W2016200608 cites W1952422131 @default.
- W2016200608 cites W2116996913 @default.
- W2016200608 cites W2124928129 @default.
- W2016200608 cites W2159027140 @default.
- W2016200608 cites W2268939434 @default.
- W2016200608 cites W2406213538 @default.
- W2016200608 doi "https://doi.org/10.1002/1097-0142(20011101)92:9<2334::aid-cncr1580>3.0.co;2-3" @default.
- W2016200608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11745288" @default.
- W2016200608 hasPublicationYear "2001" @default.
- W2016200608 type Work @default.
- W2016200608 sameAs 2016200608 @default.
- W2016200608 citedByCount "42" @default.
- W2016200608 countsByYear W20162006082012 @default.
- W2016200608 countsByYear W20162006082013 @default.
- W2016200608 countsByYear W20162006082014 @default.
- W2016200608 countsByYear W20162006082017 @default.
- W2016200608 countsByYear W20162006082018 @default.
- W2016200608 countsByYear W20162006082020 @default.
- W2016200608 countsByYear W20162006082021 @default.
- W2016200608 countsByYear W20162006082022 @default.
- W2016200608 countsByYear W20162006082023 @default.
- W2016200608 crossrefType "journal-article" @default.
- W2016200608 hasAuthorship W2016200608A5000174010 @default.
- W2016200608 hasAuthorship W2016200608A5021230077 @default.
- W2016200608 hasAuthorship W2016200608A5031440445 @default.
- W2016200608 hasAuthorship W2016200608A5033516554 @default.
- W2016200608 hasAuthorship W2016200608A5034792001 @default.
- W2016200608 hasAuthorship W2016200608A5061478990 @default.
- W2016200608 hasAuthorship W2016200608A5066416973 @default.
- W2016200608 hasAuthorship W2016200608A5088048973 @default.
- W2016200608 hasAuthorship W2016200608A5089439580 @default.
- W2016200608 hasConcept C126322002 @default.
- W2016200608 hasConcept C141071460 @default.
- W2016200608 hasConcept C143998085 @default.
- W2016200608 hasConcept C2776283816 @default.
- W2016200608 hasConcept C2776694085 @default.
- W2016200608 hasConcept C2777292972 @default.
- W2016200608 hasConcept C2777546739 @default.
- W2016200608 hasConcept C2778239845 @default.
- W2016200608 hasConcept C2781413609 @default.
- W2016200608 hasConcept C2781451048 @default.
- W2016200608 hasConcept C31760486 @default.
- W2016200608 hasConcept C509974204 @default.
- W2016200608 hasConcept C71924100 @default.
- W2016200608 hasConceptScore W2016200608C126322002 @default.
- W2016200608 hasConceptScore W2016200608C141071460 @default.
- W2016200608 hasConceptScore W2016200608C143998085 @default.
- W2016200608 hasConceptScore W2016200608C2776283816 @default.
- W2016200608 hasConceptScore W2016200608C2776694085 @default.
- W2016200608 hasConceptScore W2016200608C2777292972 @default.
- W2016200608 hasConceptScore W2016200608C2777546739 @default.
- W2016200608 hasConceptScore W2016200608C2778239845 @default.
- W2016200608 hasConceptScore W2016200608C2781413609 @default.
- W2016200608 hasConceptScore W2016200608C2781451048 @default.
- W2016200608 hasConceptScore W2016200608C31760486 @default.
- W2016200608 hasConceptScore W2016200608C509974204 @default.
- W2016200608 hasConceptScore W2016200608C71924100 @default.
- W2016200608 hasIssue "9" @default.
- W2016200608 hasLocation W20162006081 @default.
- W2016200608 hasLocation W20162006082 @default.
- W2016200608 hasOpenAccess W2016200608 @default.
- W2016200608 hasPrimaryLocation W20162006081 @default.
- W2016200608 hasRelatedWork W1502181122 @default.
- W2016200608 hasRelatedWork W2006385338 @default.
- W2016200608 hasRelatedWork W2053778437 @default.
- W2016200608 hasRelatedWork W2100029565 @default.
- W2016200608 hasRelatedWork W2289428780 @default.
- W2016200608 hasRelatedWork W2363732038 @default.
- W2016200608 hasRelatedWork W2367907813 @default.
- W2016200608 hasRelatedWork W2380099415 @default.
- W2016200608 hasRelatedWork W2415963934 @default.
- W2016200608 hasRelatedWork W4250038123 @default.
- W2016200608 hasVolume "92" @default.
- W2016200608 isParatext "false" @default.
- W2016200608 isRetracted "false" @default.
- W2016200608 magId "2016200608" @default.
- W2016200608 workType "article" @default.